Long term retention and excretion of 201Tl in a patient after myocardial perfusion imaging

Radiation Protection Dosimetry

Volumn 113, Issue 1, 2005, Pages 47-53

  Blanchardon, E ^a   Challeton de Vathaire, Cecile ^a   Boisson, P ^a   Celier D ^a   Martin, J C ^a   Cassot, S ^a   Herbelet, G ^b   Franck, D ^a   Jourdain, J R ^a   Biau, A ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM IODIDE; THALLIUM 201;

AGED; ARTICLE; BIOASSAY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EXCRETION; FOLLOW UP; FUNCTIONAL ASSESSMENT; GAMMA SPECTROMETRY; HALF LIFE TIME; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; RADIATION DETECTION; RADIATION DETECTOR; RADIATION DOSE; RADIATION MEASUREMENT; RADIOACTIVITY; RADIOISOTOPE DISTRIBUTION; TISSUE DISTRIBUTION; URINALYSIS; URINARY EXCRETION; WHOLE BODY COUNTER;

AGED; BIOLOGICAL TRANSPORT; CORONARY CIRCULATION; HUMANS; MALE; METABOLIC CLEARANCE RATE; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; THALLIUM; THALLIUM RADIOISOTOPES;

EID: 20244378070     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/nch430     Document Type: Article

References (10)

1. 201Tl as a myocardial radionuclide imaging agent in man. Invest. Radiol., 11 3), 163-171 (1976).
2. Krahwinkel, W., Herzog, H. and Feinendegen, L.E. Pharmacokinetics of thallium-201 in normal individuals after routine myocardial scintigraphy. J. Nucl. Med. 29, 1582-1586 (1998).
3. Atkins, H. L., Budinger, T. F., Lebowitz, E., Ansari, A. N., Greene, M. W., Fairchild, R. G. and Ellis, K. J. Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties J. Nucl. Med. 18, 133-140 (1977).
4. Sattari, A., Dadashzadeh, S. and Nasiroghli, G. Urinary excretion and external radiation dose from patients administered thallium-201 and technetium-99m methoxy isobutyl isonitrile. Radiat. Prot. Dosim. 95, 59-61 (2001).
5. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53 Ann. ICRP 18(1-4) (Oxford: Pergamon Press) (1987).
6. Chen, C. T., Lathrop, K. A., Harper, P. V., Bartlett, R. D., Stark V. J., Fultz, K. R. and Faulhaber, P. F. Quantitative measurement of long term in vivo thallium distribution in the human. J. Nucl. Med., 24, 50 (1983).
7. Lie, R., Thomas, R. G. and Scott J. K. The distribution and excretion of thallium-204 in the rat, with suggested MPC'S and a bio-assay procedure. Health Phys. 2, 334-340 (1960).
8. Daburon M. L. and Jeanmaire L. Guidelines for the systematic monitoring of radioactive contamination by means of in vivo measurement. CEA Report CEA-R-4458 (1973).
9. Samson, G., Wackers F. J. T. H. and Becker A. E. Distribution of thallium-201 in man. Presented at the 14th Annual Meeting of the W. German Society of Nuclear Medicine, Berlin (1976).
10. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). ICRP Publication 80. Ann. ICRP 28(3), (Oxford: Pergamon Press) (1998).